06:59 AM EST, 11/27/2024 (MT Newswires) -- GSK (GSK) said Wednesday the European Commission approved the indication of its vaccine Menveo in a fully liquid presentation for preventing a type of invasive meningococcal disease.

The liquid presentation of Menveo makes the vaccine ready to use in its liquid form without reconstitution, GSK said, adding that the indication is now licensed for children and adults.